Hypertension, a dementia polygenic risk score, APOE genotype, and incident dementia
Open Access
- 19 April 2022
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (2), 467-476
- https://doi.org/10.1002/alz.12680
Abstract
Introduction There is inconsistent evidence on whether genetic risk for dementia modifies the association between hypertension and dementia. Methods In 198,965 dementia-free participants aged >= 60 years, Cox proportional-hazards models were used to investigate the association between hypertension and incident dementia. A polygenic risk score (PRS) based on 38 non-apolipoprotein E (APOE) single nucleotide polymorphisms and APOE epsilon 4 status were used to determine genetic risk for dementia. Results Over 15 years follow-up, 6270 participants developed dementia. Hypertension was associated with a 19% increased risk of dementia (hazard ratio = 1.19, 95% confidence interval 1.11-1.27). The associations remained similar when stratifying by genetic risk, with no evidence for multiplicative interaction by dementia PRS (P = 0.20) or APOE epsilon 4 status (P = 0.16). However, the risk difference between those with and without hypertension was larger among those at higher genetic risk. Discussion Hypertension was associated with an increased risk of dementia regardless of genetic risk for dementia.Keywords
This publication has 49 references indexed in Scilit:
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Midlife vascular risk factor exposure accelerates structural brain aging and cognitive declineNeurology, 2011
- Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotesNeurology, 2011
- Hypertension is a potential risk factor for vascular dementia: systematic reviewInternational Journal of Geriatric Psychiatry, 2010
- The association of APOE genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sampleBMC Geriatrics, 2008
- Meta-analysis of APOE genotype and subarachnoid hemorrhageNeurology, 2007
- Apolipoprotein E, cardiovascular disease and cognitive function in aging womenNeurobiology of Aging, 2005
- Joint Effect of theAPOEGene and Midlife Systolic Blood Pressure on Late-Life Cognitive ImpairmentStroke, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999